富国基金朱少醒旗下基金二季报出炉！中际旭创(300308.SZ)、泽璟制药(688266.SH)首度进入前十大重仓股

智通财经07-21

智通财经APP获悉，7月21日，朱少醒管理的富国天惠成长混合(LOF)披露2026年二季报。截至二季度末，中际旭创(300308.SH)、泽璟制药(688266.SZ)首度进入该基金的前十大重仓股，分别成为第六大、第七大重仓股。同时，中国平安(601318.SH)、滨江集团(002244.SZ)再度进入该基金的前十大重仓股，徐工机械(000425.SZ)、紫金矿业(601899.SH)、瑞丰新材(...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2653322764?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-21 16:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653322764","market":"sh","top_or_hot":-1,"title":"富国基金朱少醒旗下基金二季报出炉！中际旭创(300308.SZ)、泽璟制药(688266.SH)首度进入前十大重仓股","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，7月21日，朱少醒管理的富国天惠成长混合(LOF)披露2026年二季报。截至二季度末，中际旭创(300308.SH)、泽璟制药(688266.SZ)首度进入该基金的前十大重仓股，分别成为第六大、第七大重仓股。同时，中国平安(601318.SH)、滨江集团(002244.SZ)再度进入该基金的前十大重仓股，徐工机械(000425.SZ)、紫金矿业(601899.SH)、瑞丰新材(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1470316.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>富国基金朱少醒旗下基金二季报出炉！中际旭创(300308.SZ)、泽璟制药(688266.SH)首度进入前十大重仓股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n富国基金朱少醒旗下基金二季报出炉！中际旭创(300308.SZ)、泽璟制药(688266.SH)首度进入前十大重仓股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-21 16:08 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1470316.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，7月21日，朱少醒管理的富国天惠成长混合(LOF)披露2026年二季报。截至二季度末，中际旭创(300308.SH)、泽璟制药(688266.SZ)首度进入该基金的前十大重仓股，分别成为第六大、第七大重仓股。同时，中国平安(601318.SH)、滨江集团(002244.SZ)再度进入该基金的前十大重仓股，徐工机械(000425.SZ)、紫金矿业(601899.SH)、瑞丰新材(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1470316.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1794554557.SGD","symbol_name":"Allianz All China Equity AT Acc H2-SGD","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1470316.html","article_id":"2653322764","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653322764","pubTimestamp":1784621322,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"截至二季度末，中际旭创、泽璟制药首度进入该基金的前十大重仓股，分别成为第六大、第七大重仓股。同时，中国平安、滨江集团再度进入该基金的前十大重仓股，徐工机械、紫金矿业、瑞丰新材、贵州茅台集体退出该基金的前十大重仓股。截至二季度末，该基金继续重仓持有宁波银行，并且持股数量与上个季度保持不变。截至2026年二季度末，该基金已连续24个季度重仓宁波银行，持仓市值达14.85亿元。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"91530":"广西百菲乳业股份有限公司（临时代码）","300308":"中际旭创","688266":"泽璟制药-U","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","LU2778985437.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"A\" (USD) INC","LU2177674079.SGD":"Fidelity Asia Pacific Opportunities A-ACC-SGD (hedged)","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","01477":"欧康维视生物-B","LU0469268626.HKD":"AB FCP I-ASIA EX JAPAN EQUITY PTF(AD","LU2476274720.SGD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (SGDHDG) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","SGXZ49509284.SGD":"United China A Shares Innovation A Acc SGD","LU2399975544.HKD":"ALLIANZ ALL CHINA EQUITY \"AT\" (HKD) ACC","BK1191":"制药","SG9999011746.SGD":"PINEBRIDGE INTERNATIONAL FUNDS - ACORNS OF ASIA BA (SGD) ACC","LU0082770016.SGD":"HSBC GIF ASIA EX JAPAN EQUITY SMALLER COMPANIES \"AD\" (SGD) INC","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","LU0348827113.USD":"ALLIANZ RCM CHINA \"AT\" ACC","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","IE0032431581.USD":"PINEBRIDGE GREATER CHINA EQUITY \"A\" (USD) ACC","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","BK0070":"员工持股","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","IE0034224299.USD":"PINEBRIDGE ASIA EX JAPAN EQUITY \"A\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU1997245177.USD":"安联神洲A股基金","LU0164939612.USD":"HSBC GIF ASIA EX JAPAN SMALLER CO. \"AC\" ACC","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU1720050803.USD":"安联全方位中国股票基金","LU0210526637.USD":"JPM CHINA \"A\" (USD) ACC","LU2008162690.USD":"FIDELITY FUNDS - ASIA PACIFIC OPPORTUNITIES \"A\" (USD) ACC","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","LU1961090484.USD":"ALLIANZ ALL CHINA EQUITY \"A\" (USD) INC","LU1303224171.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) INC","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","LU0231483743.USD":"abrdn SICAV I - ALL CHINA SUSTAINABLE EQUITY \"A\" (USD) ACC","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","LU0871576103.HKD":"HSBC GIF CHINESE EQUITY \"AC\" (HKD) ACC","LU2476274308.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (USD) ACC","BK0167":"5G","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD"},"translate_title":"The second quarterly report of Zhu Shaoxing's fund of Wells Fargo Fund is released! Zhongji InnoLight (300308.SZ) and Zejing Pharmaceutical (688266.SH) entered the top ten holding stocks for the first time","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91530":1.5,"300308":1.5,"688266":1.5,"01477":1.5},"content_text":"智通财经APP获悉，7月21日，朱少醒管理的富国天惠成长混合(LOF)披露2026年二季报。截至二季度末，中际旭创(300308.SH)、泽璟制药(688266.SZ)首度进入该基金的前十大重仓股，分别成为第六大、第七大重仓股。同时，中国平安(601318.SH)、滨江集团(002244.SZ)再度进入该基金的前十大重仓股，徐工机械(000425.SZ)、紫金矿业(601899.SH)、瑞丰新材(300910.SZ)、贵州茅台(600519.SH)集体退出该基金的前十大重仓股。截至二季度末，该基金继续重仓持有宁波银行(002142.SZ)，并且持股数量与上个季度保持不变。截至2026年二季度末，该基金已连续24个季度重仓宁波银行，持仓市值达14.85亿元。该基金还增持春风动力(603129.SH)、广钢气体(688548.SH)，减持国瓷材料(300285.SZ)、杰瑞股份(002353.SZ)、宁德时代(300750.SZ)。截止2026年二季度末，基金份额净值增长率情况方面，富国天惠成长混合(LOF)A/B为14.45%，富国天惠成长混合(LOF)C为14.22%，富国天惠成长混合(LOF)D为14.45%；同期业绩比较基准收益率情况方面，富国天惠成长混合(LOF)A/B为8.47%，富国天惠成长混合(LOF)C为8.47%，富国天惠成长混合(LOF)D为8.47%。朱少醒在二季报中表示，未来依然会致力于在优质股票里寻找价值。我们并不具备精确预测市场短期趋势的可靠能力，而是把精力集中在耐心收集具有远大前景的优秀公司，等待公司自身创造价值的实现和市场情绪在未来某个时点的周期性回归。个股选择层面，本基金偏好投资于具有良好“企业基因”，公司治理结构完善、管理优秀的企业，认为此类企业有更大的概率能在未来为投资者创造价值。分享企业自身增长带来的资本市场收益是成长型基金获取回报的重要途径。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2653322764","isCrawlerRequest":true}